Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Intrahepatic Cholangiocarcinoma by AJCC v7 Stage	NCIT_C134514	[A term that refers to the staging of intrahepatic cholangiocarcinoma according to the American Joint Committee on Cancer, 7th edition.]
Primary Intraosseous Squamous Cell Carcinoma Derived From Odontogenic Cyst	NCIT_C7500	[A rare squamous cell carcinoma that arises centrally from the jaw from the lining of an odontogenic cyst.]
Odontogenic Myxoma	NCIT_C7501	[An intraosseous odontogenic neoplasm with good prognosis, arising from the mandible and less frequently from the maxilla. It is characterized by the presence of stellate cells and abundant myxoid stroma formation. Small tumors may be cured with enucleation. Complete excision may be required for larger tumors.]
Urethra Neoplasm	NCIT_C3428	[A benign or malignant neoplasm that affects the urethra. Urethral carcinoma is a representative example.]
Malignant Urinary System Neoplasm	NCIT_C9297	[A primary or metastatic malignant tumor involving the urinary system. Common tumor types include carcinomas, lymphomas, and sarcomas.]
Recurrent Urethral Carcinoma	NCIT_C7508	[The reemergence of urethral carcinoma after a period of remission]
Urethral Carcinoma	NCIT_C9106	[A carcinoma that arises from the urethra. Morphologically, the tumors are similar to those described in the bladder.]
Metastatic Malignant Neoplasm in the Thyroid Gland	NCIT_C7509	[A malignant neoplasm either directly extending to the thyroid gland from adjacent structures (e.g. pharynx, larynx, esophagus, cervical lymph nodes), or spreading to the thyroid gland from distant anatomic sites, most frequently kidney, lung, uterus, breast, and skin. The majority of cases are carcinomas, lymphomas, and melanomas.]
Stage I Intrahepatic Cholangiocarcinoma AJCC v7	NCIT_C88050	[Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Anti-CD19-CAR Retroviral Vector-Transduced Autologous T Cells	NCIT_C88055	[A preparation of autologous peripheral blood T-lymphocytes (PBTL) that have been genetically modified to express a chimeric antigen receptor (CAR) consisting of an anti-CD19 scFv (single chain variable fragment) coupled to the costimulatory signaling domain CD28 and the zeta chain of the T-cell receptor (TCR)/CD3 complex (CD3 zeta), with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD19-CAR retroviral vector-transduced autologous T cells direct the T-lymphocytes to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies. CD3 zeta is one of several membrane-bound polypeptides found in the TCR/CD3 complex, which regulates both the assembly of complete TCR complexes and their expression on the cell surface. CD28 is essential for CD4+ T-cell proliferation, interleukin-2 production, and T-helper type-2 (Th2) development.]
Stage IIIA Gallbladder Cancer AJCC v7	NCIT_C88056	[Stage IIIA includes: T3, N0, M0. T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage III Gallbladder Cancer AJCC v7	NCIT_C90218	[Stage III includes: IIIA (T3, N0, M0); IIIB (T1-3, N1, M0). T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. T1: Tumor invades lamina propria or muscular layer. T2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver. N0: No regional lymph node metastasis. N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage IIIB Gallbladder Cancer AJCC v7	NCIT_C88057	[Stage IIIB includes: T1-3, N1, M0. T1: Tumor invades lamina propria or muscular layer. T2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver. T3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts. N1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage 0 Hilar Cholangiocarcinoma AJCC v7	NCIT_C88058	[Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage II Intrahepatic Cholangiocarcinoma AJCC v7	NCIT_C88051	[Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage III Intrahepatic Cholangiocarcinoma AJCC v7	NCIT_C88052	[Stage III includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum or involving the local extra hepatic structures by direct invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7	NCIT_C88053	[Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)]
Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7	NCIT_C88054	[Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.)]
Malignant Esophageal Neoplasm by Topographic Region	NCIT_C7513	[Esophageal segments used primarily in pathology, and distinct from the anatomic segments used for clinical purposes.]
Kidney and Ureter Neoplasm	NCIT_C7514	[A benign or malignant, primary or metastatic neoplasm affecting the kidney and ureter.]